Siddhartha Devarakonda, MBBS, MD
Dr. Sid Devarakonda trained and worked on faculty at the Washington University in St. Louis before joining Swedish Cancer Institute in Seattle as the Director of Thoracic Medical Oncology and Washington State University as an Associate Professor. His research is focused on understanding cancers utilizing sequencing technologies. He has been a part of consortia such as TCGA. He is particularly interested in understanding the molecular underpinnings of never-smoker lung cancer and mechanisms of treatment resistance in lung cancers.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:AstraZenecaDate added:04/03/2024Date updated:05/17/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:JazzDate added:04/03/2024Date updated:05/17/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:GenentechDate added:04/03/2024Date updated:05/17/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:TakedaDate added:04/03/2024Date updated:05/17/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:Eli LillyDate added:04/03/2024Date updated:05/17/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:Daiichi-SankyoDate added:04/03/2024Date updated:05/17/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:ApollomicsDate added:04/03/2024Date updated:05/17/2024